Skip to content

Eclipse PLUS

by Apex Biotechnology Corp.

Ref M034

Eclipse PLUS (M034) is an in vitro diagnostic device (EU IVDR Class A; EMDN category glycosilated hemoglobin devices) made by Apex Biotechnology Corp., registered in EUDAMED on 21 May 2026 (Basic UDI-DI 47136487606B00MCSa73), active as of 24 Oct 2026.

Active European Union

CE IVDR

Valid until

No date given

EUDAMED holds no validity date

FDA recalls

Not applicable

No FDA record for this device

Documents

None, self-declared

Class I: no certifier involved

Trust

Unverified

Source EUDAMED, synced 24 Oct 2026.

Regulatory status

as of registry sync 24 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDR Number47136487606B00MCSa73 Basic UDI-DI 04713648762198UDI-DIDate21 May 2026RegisteredStatusActive

Official records

Certificates

0 certificates · EUDAMED

No certifier certificate is listed. Devices of this class are self-declared by the manufacturer.

Coverage

1 jurisdiction

SwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

European Union — CE/IVDR Active

Specification

EUDAMED

Device name
Eclipse PLUS Multi-Purpose Analyzer
Model / reference
M034
Primary DI / UDI-DI
04713648762198
Basic UDI-DI
47136487606B00MCSa73
Direct marketing DI
04713648762198
EMDN code
W0201060101 Glycosilated hemoglobin devices
Device class
Class A
EU registration type
Standard device
EU market of registration
Germany

Manufacturer details

EUDAMED SRN
TW-MF-000019773
Authorised representative
Obelis s.a. BE-AR-000000106

Similar devices in this category

Other devices filed under GLYCOSILATED HEMOGLOBIN DEVICES.

Other devices from Apex Biotechnology Corp.

See all devices from Apex Biotechnology Corp. →

Properties

  • Near-patient testing
  • IVD instrument
Other properties (11, all answered No)